Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Irinotecan | FIMM | pan-cancer | AAC | 0.043 | 0.7 |
mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |